BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 315754)

  • 1. Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.
    Hughes WT
    Antimicrob Agents Chemother; 1979 Sep; 16(3):333-5. PubMed ID: 315754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
    Hughes WT; Smith BL; Jacobus DP
    Antimicrob Agents Chemother; 1986 Mar; 29(3):509-10. PubMed ID: 3487287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
    D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
    Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.
    Hughes WT; McNabb PC; Makres TD; Feldman S
    Antimicrob Agents Chemother; 1974 Mar; 5(3):289-93. PubMed ID: 4365115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.
    Mitsuyasu RT; Corwin HL; Harris AA; Trenholme GM; Levi S; Karkusis PH
    Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.
    Kluge RM; Spaulding DM; Spain AJ
    Antimicrob Agents Chemother; 1978 Jun; 13(6):975-8. PubMed ID: 307941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
    Hughes WT
    Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of pneumocystis pneumonia. Use of continuous sulfamethoxazole-trimethroprim therapy.
    Harris RE; McCallister JA; Allen SA; Barton AS; Baehner RL
    Am J Dis Child; 1980 Jan; 134(1):35-8. PubMed ID: 6965335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis carinii pneumonitis successfully treated with trimethoprim-sulphamethoxazole.
    McLennan G; Antic R; Seymour AE; Frith PA; Clarkson AR
    Aust N Z J Med; 1977 Jun; 7(3):299-301. PubMed ID: 303097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.
    Hughes WT; Kuhn S; Chaudhary S; Feldman S; Verzosa M; Aur RJ; Pratt C; George SL
    N Engl J Med; 1977 Dec; 297(26):1419-26. PubMed ID: 412099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Implication of folinic acid.
    Nunn PP; Allistone JC
    Chest; 1984 Jul; 86(1):149-50. PubMed ID: 6610537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions.
    Shafer RW; Seitzman PA; Tapper ML
    J Acquir Immune Defic Syndr (1988); 1989; 2(4):389-93. PubMed ID: 2526871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of rats free of latent Pneumocystis carinii.
    Bartlett MS; Durkin MM; Jay MA; Queener SF; Smith JW
    J Clin Microbiol; 1987 Sep; 25(9):1794-5. PubMed ID: 2958497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
    Clarkson AB; Williams DE; Rosenberg C
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1158-63. PubMed ID: 3142346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
    Hughes WT; Killmar J
    Antimicrob Agents Chemother; 1996 Apr; 40(4):962-5. PubMed ID: 8849260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia.
    Hughes WT; Smith BL
    Antimicrob Agents Chemother; 1983 Aug; 24(2):300-1. PubMed ID: 6605717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulfonylurea compounds on Pneumocystis carinii.
    Hughes WT; Smith-McCain BL
    J Infect Dis; 1986 May; 153(5):944-7. PubMed ID: 3486236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
    Fischl MA; Dickinson GM; La Voie L
    JAMA; 1988 Feb; 259(8):1185-9. PubMed ID: 3257532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonitis in children.
    Hughes WT
    Rev Infect Dis; 1982; 4(2):602-7. PubMed ID: 6981176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.